调控DNA同源重组修复的PALB2、BRCA1和RAD51C基因种系突变与胃癌患者
研究对28例无CDH1突变的遗传性弥漫性胃癌(HDGC)患者行全外显子测序,并在333例独立HDGC及非HDGC病例中分析候选基因。在11例患者中检出PALB2、BRCA1或RAD51C基因突变,HDGC中占6.5%(2/31),散发性胃癌中占2.8%(9/331)。携带突变患者的肿瘤具有体细胞同源重组缺陷相关突变特征,提示同源重组缺陷增加胃癌风险。
要点
- 在无CDH1突变的HDGC及散发性胃癌中检出PALB2、BRCA1、RAD51C种系突变。
- HDGC患者突变频率为6.5%(2/31),散发性胃癌为2.8%(9/331)。
- 携带突变患者的肿瘤具有体细胞同源重组缺陷相关突变特征。
核心结论
- 同源重组缺陷增加胃癌风险。
研究设计与样本
- 对28例无CDH1突变的遗传性弥漫性胃癌(HDGC)患者采集血样行全外显子测序,并在333例独立HDGC及非HDGC病例中分析候选基因序列。
主要发现
- 在11例患者中检出PALB2、BRCA1或RAD51C基因突变,这些基因调控同源DNA重组。
- HDGC患者中突变频率为6.5%(2/31),散发性胃癌患者中为2.8%(9/331)。
- 多数突变此前已与其他类型肿瘤相关,并在本研究中与胃癌部分共分离。
- 携带这些突变患者的肿瘤具有与体细胞同源重组缺陷相关的突变特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Up to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.
引用
- Sahasrabudhe R, Lott P, Bohorquez M, et al. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer. Gastroenterology. 2016. PMID: 28024868. doi:10.1053/j.gastro.2016.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。